Psychotropic Medications for Depression

View episode transcriptFeatured guest: Amy VandenBerg, PharmD, BCPPObjectives· Identify appropriate selective serotonin reuptake inhibitors for the management of depression in pediatric patients and how they work.· Identify appropriate serotonin-norepinephrine reuptake inhibitors for the management of depression in pediatric patients and how they work.· Discuss the black-box warning associated with these medications.· Identify symptoms of serotonin syndrome.· Identify symptoms of discontinuation syndrome.Resources· Selective serotonin reuptake inhibitors (StatPearls)· Demystifying serotonin syndrome (or serotonin toxicity) (Canadian Family Physician)· Antidepressant discontinuation syndrome (Canadian Medical Association Journal)· Antidepressants and the FDA’s black-box warning: determining a rational public policy in the absence of sufficient evidence (AMA Journal of Ethics)· Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison (Innovations in Clinical Neuroscience)CME Credits available: 0.5To enroll for CME credit, visit our episode activity website. Visit our CME course overview page for details on CME credit, or complete this survey for social work CEUs.Visit our podcast website for more information about this episode and the Breaking Down Mental Health podcast series.Breaking Down Mental Health is a part of the Michigan Medicine Podcast Network. You can subscribe to Breaking Down Mental Health podcast wherever you listen to podcasts. Hosted on Acast. See acast.com/privacy for more information.